UBS Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-14,000
| Closed | -$1.62M | – | 9842 |
|
|
2020
Q4 | $1.62M | Hold |
14,000
| – | – | ﹤0.01% | 3587 |
|
|
2020
Q3 | $1.36M | Hold |
14,000
| – | – | ﹤0.01% | 3409 |
|
|
2020
Q2 | $1.72M | Sell |
14,000
-23,400
| -63% | -$2.65M | ﹤0.01% | 3019 |
|
|
2020
Q1 | $3.27M | Sell |
37,400
-75,000
| -67% | -$7.94M | ﹤0.01% | 2296 |
|
|
2019
Q4 | $11.8M | Buy |
+112,400
| New | +$12.6M | ﹤0.01% | 1813 |
|
|
2019
Q3 | – | Sell |
-2,100
| Closed | -$362K | – | 8425 |
|
|
2019
Q2 | $362K | Buy |
+2,100
| New | +$363K | ﹤0.01% | 4519 |
|
|
2017
Q2 | – | Sell |
-100,000
| Closed | -$12.1M | – | 8135 |
|
|
2017
Q1 | $12.1M | Hold |
100,000
| – | – | 0.01% | 1351 |
|
|
2016
Q4 | $11.2M | Buy |
+100,000
| New | +$12M | 0.01% | 1411 |
|
|
2016
Q3 | – | Sell |
-48,400
| Closed | -$4.43M | – | 8072 |
|
|
2016
Q2 | $4.43M | Buy |
+48,400
| New | +$4.07M | ﹤0.01% | 2050 |
|
|
2015
Q3 | – | Sell |
-800
| Closed | -$98K | – | 8761 |
|
|
2015
Q2 | $98K | Hold |
800
| – | – | ﹤0.01% | 5427 |
|
|
2015
Q1 | $73K | Buy |
800
+100
| +14% | +$8.12K | ﹤0.01% | 5694 |
|
|
2014
Q4 | $47K | Buy |
+700
| New | +$51.1K | ﹤0.01% | 6567 |
|
Other funds holding GWPH
UBS Group's GWPH Position: Q2 2021 in Review
UBS Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 35,553 shares — an estimated $7.71M sold.
UBS Group first reported a position in GWPH in Q4 2014 and held it in 26 quarters. The position peaked at $18.6M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- UBS Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- UBS Group sold 35,553 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $7.71M.
- UBS Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 26 quarters.
- UBS Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $18.6M in Q2 2019.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.